Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2026C700 Product name: talquétamab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2026C/700
Type:
Certificate
SPC type:
Medical
Basic patent number:
177459518
Status:
Open & Published
Publication number:
2026C700
1rst applicant's nationality:
Procedural language:
French

Marketing authorization

Marketing authorization number:
EU/1/23/1748
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
22/08/2023
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
12/01/2026
First marketing authorization date:
22/08/2023
Grant date:
Activation date:
BE Publication date:
03/02/2026
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
22/08/2038
SPC/SPC Extension Expiration (if granted and all annual fees paid):
Rejection date:
Withdrawal date:

Applicant

Name:
Janssen Biotech, Inc.
Legal Form:
Inc.
From:
12/01/2026
Address:
800/850 Ridgeview Drive, 19044, Horsham, United States (US)
To:

Agent

Name:
KIRKPATRICK
Legal Form:
S.A.
From:
12/01/2026
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:

Publication

Bulletin

Bulletin heading:
SPC
Journal edition number:
2026/03
Publication date:
26/02/2026
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
Filing date Document type Publication Type Document Description Number of pages File Type
12/01/2026 Abstract Product Characteristics Abstract of the characteristics of the product 54 PDF /9/9/1/1/2/0722621199/docs/2026c700_0_abstractproductcharacteristics_20260113_084537171.pdf
12/01/2026 General Document Other 107 PDF /9/9/1/1/2/0722621199/docs/2026c700_1_generaldocument_20260113_084536946.pdf
03/02/2026 Publication I1 1 PDF /9/9/1/1/2/0722621199/docs/2026c700_2_i1document_20260203_160626596.pdf
12/01/2026 General Document Other 5 PDF /9/9/1/1/2/0722621199/docs/2026c700_3_generaldocument_20260113_084536808.pdf
12/01/2026 General Document Other 4 PDF /9/9/1/1/2/0722621199/docs/2026c700_4_generaldocument_20260113_084536668.pdf
12/01/2026 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /9/9/1/1/2/0722621199/docs/2026c700_5_marketingauthorization_20260113_084537782.pdf
12/01/2026 MA Official Publication Official Publication of 1st Marketing Authorization 9 PDF /9/9/1/1/2/0722621199/docs/2026c700_6_maofficialpublication_20260113_084537510.pdf
12/01/2026 Application Form 6 PDF /9/9/1/1/2/0722621199/docs/2026c700_7_applicationform_20260113_084537939.pdf